Could this Cheap, Generic Drug Get Us Out of the Pandemic? The Story of Fluvoxamine with Dr. Eric Lenze

Send us Fan MailFluvoxamine is a cheap, generic, oral drug that is classified and used as an antidepressant. That said, recent trials have tested its use as early, at-home treatment for COVID-19 with promising results. In fact, an application was recently submitted to the FDA for emergency use authorization as early treatment for COVID-19. (It has not been approved as of the publication of this podcast.) In this episode of Causes or Cures, Dr. Eeks chats with Dr. Eric Lenze, a psychiatrist and clinical trialist at Washington University in St. Louis, who ran one of the randomized controlled trials on fluvoxamine. His study was published here in JAMA. In this episode, he will discuss what fluvoxamine is, why he and his team decided to study its use against COVID-19, results of the trial and subsequent trials, dosing issues, side effects, concerns about withdrawal and how the drug may help bring an end to the pandemic. It's important to keep in mind that nothing yet is proven, and this is just a conversation about research and results.  You can contact Dr. Eeks at bloomingwellness.com.Follow Dr. Eeks on Instagram here.Or Facebook here.Subcribe to her newsletter here!Support the show